title: Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo.
abstract: Inhibitors in myelin play a major role in preventing spontaneous axonal regeneration after CNS injury. Elevation of cAMP overcomes this inhibition, in a transcription-dependent manner, through the upregulation of Arginase I (Arg I) and increased synthesis of polyamines. Here, we show that the cAMP effect requires activation of the transcription factor cAMP response element binding protein (CREB) to overcome myelin inhibitors; a dominant-negative CREB abolishes the effect, and neurons expressing a constitutively active form of CREB are not inhibited. Activation of CREB is also required for cAMP to upregulate Arg I, and the ability of constitutively active CREB to overcome inhibition is blocked by an inhibitor of polyamine synthesis. Finally, expression of constitutively active CREB in DRG neurons is sufficient to promote regeneration of subsequently lesioned dorsal column axons. These results indicate that CREB plays a central role in overcoming myelin inhibitors and so encourages regeneration in vivo.
authors.affiliation: Biology Department, Hunter College, City University of New York, 695 Park Avenue, New York, NY 10021, USA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Gao
authors.forename: Kangwen
authors.initials: K
authors.lastname: Deng
authors.forename: Jianwei
authors.initials: J
authors.lastname: Hou
authors.forename: J Barney
authors.initials: JB
authors.lastname: Bryson
authors.forename: Angel
authors.initials: A
authors.lastname: Barco
authors.forename: Elena
authors.initials: E
authors.lastname: Nikulina
authors.forename: Tim
authors.initials: T
authors.lastname: Spencer
authors.forename: Wilfredo
authors.initials: W
authors.lastname: Mellado
authors.forename: Eric R
authors.initials: ER
authors.lastname: Kandel
authors.forename: Marie T
authors.initials: MT
authors.lastname: Filbin
mesh_terms: D000818:Animals; D001119:Arginase / Q000378:metabolism; D001369:Axons / Q000378:metabolism* / Q000473:pathology; D015153:Blotting, Western; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009186:Myelin Sheath / Q000378:metabolism*; D018992:Myelin-Associated Glycoprotein / Q000378:metabolism; D009416:Nerve Regeneration / Q000502:physiology*; D051381:Rats; D020318:Rats, Long-Evans
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D017362:Cyclic AMP Response Element-Binding Protein; D018992:Myelin-Associated Glycoprotein; D000242:Cyclic AMP; D001119:Arginase